The NIH Rapid Acceleration of Diagnostics (RADxSM) Initiative aims to accelerate the development and commercialization of diagnostic tests to detect the SARS-CoV-2 virus. Two RADxSM programs within this Initiative—RADxSM Tech and RADxSM ATP (Advanced Technology Platforms) —are supporting late stage development of innovative point-of-care and home-based tests, as well as improved clinical laboratory tests that will increase the capacity of testing in the U.S.
Key Terms Used in Project Details:
Test Setting – location where the test is designed to be administered. Types of test settings:
POC - (Point of Care) - a clinic, physician office, pharmacy, mass testing site, organization, or other location where test sample is collected and processed by a health care professional or trained individual. Considered a rapid test and results are provided at the time of testing in 30 minutes or less. Lab – a test sample collected by health care professionals or self-collected and sent to a lab for processing. Results are provided in one day or longer.
Mobile lab – a test sample is collected and processed at the mobile lab site. Considered a rapid test and results are provided at the site in 30 minutes or less.
Home – a test sample is self-collected and processed by an individual in their own home. Considered a rapid test and results are provided in 30 minutes or less.
Status - listed as Active or Inactive. Active means a contract has been awarded and is ongoing. Inactive means a contract has completed the performance period or the contract has been terminated.
Estimated budget - reflects the budget amount of the executed contract. This amount may be updated between the award of a letter contract and final executed contract.
Actual budget - reflects the total amount spent after the contract has ended.
Data Updated: 01/12/2021.